EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

The efficacy and safety of panax quinquefolius saponin for heart failure: a systematic review and meta-analysis

Wirksamkeit und Sicherheit von Panax quinquefolius saponin bei Herzinsuffizienz: systematische Übersicht und Metaanalyse

Jing Wang, Tianying Chang, Zheng Liang, Yingzi Cui, Xiaodan Wang, Lisha Wang, Hongguang Jin

Frontiers in Pharmacology · 28.02.2025 · 16

DOI: 10.3389/fphar.2025.1463609 ↗

Auf einen Blick

Neun RCTs mit 952 Patient:innen mit Herzinsuffizienz wurden ausgewertet. Zusätzliche PQS-Therapie war mit besseren Herzfunktions- und Belastungsparametern verbunden.

Fragestellung

Wie wirksam und sicher ist Panax quinquefolius saponin (PQS) bei Herzinsuffizienz?

Methode

Systematische Übersicht und Metaanalyse von RCTs; Suche in 8 Datenbanken bis März 2024; Bewertung mit ROB 2.0 und GRADEpro.

Ergebnisse

9 RCTs mit 952 Patient:innen. PQS erhöhte LVEF (MD 6,23; 95 %-KI 4,35–8,12), 6MWTD (MD 25,26; 95 %-KI 8,23–42,30) und senkte BNP/NT-pro-BNP, LVEDV, LVEDD und LVESV.

Einschränkungen

Die Autor:innen nennen Einschränkungen der Übersicht; die Schlussfolgerungen sollen vorsichtig interpretiert werden.

Schlussfolgerung der Autor:innen

Die Evidenz spricht dafür, dass adjuvante PQS-Therapie die klinische Wirksamkeit verbessern und Herzfunktion sowie Belastungstoleranz erhöhen kann.

Kernaussagen

  • LVEF stieg unter PQS um MD 6,23 (95 %-KI 4,35–8,12)
  • 6MWTD nahm zu, BNP/NT-pro-BNP und linksventrikuläre Maße nahmen ab
  • Die Autor:innen raten zu vorsichtiger Interpretation der Ergebnisse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.02.2025. Verfasst von Jing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) is a global health concern, affecting millions of individuals worldwide and leading to significant morbidity and mortality. Despite advances in conventional therapeutic strategies, the prognosis for HF patients remains challenging, and there is a constant search for novel therapeutic options. Among these, Panax quinquefolius saponin (PQS) has demonstrated promising pharmacological properties that may benefit HF. However, the efficacy and safety of PQS for HF have not been comprehensively evaluated.

Objective

This systematic review and meta-analysis aim to provide a more reliable estimation of the efficacy and safety of PQS for HF. This will help clinicians make informed decisions regarding the potential use of PQS in managing HF patients.

Methods

We comprehensively and systematically searched for published randomized controlled trials (RCTs) in the following eight electronic databases: PubMed, Cochrane Library, EMBASE, Web of Science (WOS), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Data, and China Biology Medicine Database (CBM) from database inception to March 2024. The Cochrane risk of bias (ROB 2.0) assessment tool was used for quality assessment, and Review Manager (RevMan, version 5.4) was used for meta-analysis. Mean difference (MD), 95% credible interval (CI), and relative risk (RR) estimates were calculated under a random-effects model. We also used GRADE profiler (GRADEpro, version 3.6) to analyze the quality of outcomes. In addition, the protocol has been registered in International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY) under registry number 202440050.

Results

This study included nine RCTs involving a total of 952 patients with HF. The results of a meta-analysis under a random-effects model showed that adjuvant PQS therapy significantly increased LVEF (MD = 6.23, 95% CI [4.35, 8.12], P < 0.00001), 6MWTD (MD = 25.26, 95% CI [8.23, 42.30], P = 0.004), and decreased BNP/NT-pro-BNP (MD = −187.94, 95% CI [−267.20, −108.67], P < 0.00001), LVEDV (MD = −22.83, 95% CI [−42.79, −2.87], P = 0.02), LVEDD (MD = −4.76, 95% CI [−5.77, −3.74], P < 0.00001), and LVESV (MD = −11.86, 95% CI [−19.89, −3.83], P = 0.004) in patients with HF.

Conclusion

The evidence provided by this systematic review suggests that adjunctive PQS therapy for HF can improved clinical efficacy and holds potential advantages in improving cardiac function and increasing exercise tolerance. However, given the limitations inherent in this review, the conclusions of this study should be interpreted cautiously. Therefore, in clinical practice, it is recommended that physicians tailor treatment strategies according to the specific circumstances of individual patients. Systematic Review registration https://inplasy.com/?s=202440050

Schlagwörter

Stichwörter der Autor:innen

efficacy and safetyheart failuremeta-analysispanax quinquefolius saponinsystematic review

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • EBM office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Department of Cardiology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Zitieren

APA

Wang, J., Chang, T., Liang, Z., Cui, Y., Wang, X., Wang, L., & Jin, H. (2025). The efficacy and safety of panax quinquefolius saponin for heart failure: a systematic review and meta-analysis. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1463609

Vancouver

Wang J, Chang T, Liang Z, Cui Y, Wang X, Wang L, et al. The efficacy and safety of panax quinquefolius saponin for heart failure: a systematic review and meta-analysis. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1463609

BibTeX
@article{Wang2025,
  author = {Wang, Jing and Chang, Tianying and Liang, Zheng and Cui, Yingzi and Wang, Xiaodan and Wang, Lisha and Jin, Hongguang},
  title = {The efficacy and safety of panax quinquefolius saponin for heart failure: a systematic review and meta-analysis},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1463609}
}
Kostenlos starten →